Bharat Biotech, Zydus Cadila COVID-19 vaccine in phase 2 trial, says VK Paul

"In India, Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR is in the Phase II trial along with Zydus Cadila's candidate which is based on viral DNA. The Oxford vaccine candidate developed by Serum Institute of India is already in Phase III trial in Maharashtra and some other States," he said.

Read Also: Oxford COVID vaccine phase 2 trial to begin in PGI Chandigarh

Dr Paul also informed the meeting about the progress made by the National Expert Group on Vaccine Administration for COVID-19.

The group is tasked with the facilitation of vaccine development including issues of trial and stockpiling, sorting out issues of financing, risk management, selection of potential beneficiaries and their order of reference, envisioning logistics, scale-up, digital system, defining principles for selecting beneficiary categories, and defining the scientific basis for selecting vaccine.

Three meetings of the expert group have been held so far, the release said.

Read Also: French drugmaker Sanofi more confident about its COVID vaccines: Report